BSE · 544482
Star Imaging and Path Lab Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹84 Cr with net profit ₹16 Cr — a 19.01% net margin, versus 15.53% the period before.
Shareholding
As of 2026-03-31
- Promoter71.92%
- Public21.33%
- FII0.61%
- DII6.14%
773 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.3× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Healthcare · ranked #1 of 79 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,29,234 Cr | 244.11 | 13.63 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,09,470 Cr | 73.81 | 10.19 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,634 Cr | 269.56 | 7.24 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,513 Cr | 50.7 | 9.37 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,038 Cr | 298.29 | 9.19 | 8.48% | 8.36% |
| Global Health Limited | ₹38,082 Cr | 264.25 | 9.61 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,895 Cr | 136.55 | 9.04 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,496 Cr | 239.03 | 12.55 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,888 Cr | 51.6 | 5.44 | 10.37% | 17.18% |
| Rainbow Childrens Medicare Ltd. | ₹15,420 Cr | 62.33 | 9.24 | 16.89% | 16.34% |
| Star Imaging and Path Lab Ltd.(this company) | — | — | — | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashStar Imaging and Path Lab Ltd. is under ESM Stage 1 surveillance. The company reported a revenue of Rs 83.7874 Cr in March 2025, with a net profit of Rs 15.9262 Cr. The 52-week high for the share price was Rs 152 and the 52-week low was Rs 46.
Positives
- +Promoter holding of 71.9158% as of March 2026 is stable.
- +Debt-to-equity ratio is 0.81, indicating moderate leverage.
- +Promoter shareholding has no pledges (0%).
- +Net profit increased to Rs 15.9262 Cr in March 2025 from Rs 12.4176 Cr in March 2024.
Negatives
- −The company is under ESM Stage 1 surveillance, which may indicate closer regulatory monitoring.
- −Public shareholding increased to 21.3333% in March 2026 from 0.002% in March 2025, potentially due to reclassification of promoter holding.
- −DII holding decreased to 6.1424% in March 2026 from 9.3284% in September 2025.
- −FII holding decreased to 0.6085% in March 2026 from 1.372% in September 2025.
Financial Performance
Star Imaging and Path Lab Ltd. saw its revenue increase to Rs 83.7874 Cr in March 2025 from Rs 79.9742 Cr in March 2024. Net profit also rose to Rs 15.9262 Cr in March 2025 from Rs 12.4176 Cr in March 2024. Earnings per share (EPS) improved to Rs 11.8 in March 2025 compared to Rs 82.78 in March 2024. EBITDA for March 2025 stood at Rs 23.9303 Cr.
Profitability & Returns
The company's net profit increased to Rs 15.9262 Cr in March 2025 from Rs 12.4176 Cr in March 2024. Earnings per share (EPS) for March 2025 was Rs 11.8, following Rs 82.78 in March 2024 and Rs 3.89 in March 2023. This indicates a consistent trend in profitability over the last three fiscal years.
Balance Sheet
Star Imaging and Path Lab Ltd. has a debt-to-equity ratio of 0.81. No other specific balance sheet figures such as market capitalization, book value, or current assets and liabilities were provided in the data.
Ownership & Pledges
As of March 2026, promoters maintain a significant stake of 71.9158%. DII holding stood at 6.1424% while FII holding was 0.6085%. There are no pledged promoter shares as of March 2026.
Regulatory & Surveillance
Star Imaging and Path Lab Ltd. is currently under ESM Stage 1 surveillance. This indicates certain regulatory measures in place for the stock. The company has 773 shareholders as of March 2026.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Star Imaging and Path Lab Ltd.share price & fundamentals